What We Are Learning About Brain Biology and Borderline Personality Disorder
Tuesday, June 8, 2021, 2:00 pm EDT
In this presentation, Dr. Ruocco discusses his new research on the neurobiology of borderline personality disorder, including the familial risk for the disorder and the impacts of stress on brain structure and functioning. He also presents the results of his research funded by the Brain & Behavior Research Foundation examining the treatment of suicidal ideation and depression using magnetic seizure therapy in individuals with borderline personality disorder.
Watch webinar recording:
Please use #BBRFWebinar when sharing or posting about our Meet the Scientist Webinars on social media.
Dr. Ruocco is an Associate Professor in the Department of Psychology and Program in Neuroscience at the University of Toronto Scarborough and the Graduate Departments of Psychology and Psychological Clinical Science at the University of Toronto. He holds academic appointments at the Centre for Addiction & Mental Health in the Mood & Anxiety Division and the Hospital for Sick Children in the Department of Diagnostic Imaging and the Neurosciences and Mental Health Program. Dr. Ruocco is a licensed psychologist registered with the College of Psychologists of Ontario. His research uses neurocognitive and brain-imaging measures to understand the pathophysiology underlying severe mental disorders, especially borderline personality disorder (BPD). His current studies focus on identifying neurocognitive and neural markers in adolescents and adults with BPD and their biological relatives, and he is studying the utility of these markers to predict the outcomes of psychological and brain stimulation interventions for suicidal and self-harming individuals with BPD.
Jeffrey Borenstein, M.D., serves as the President & CEO of the Brain & Behavior Research Foundation, the largest private funder of mental health research grants. Dr. Borenstein developed the Emmy-nominated public television program “Healthy Minds,” and serves as host and executive producer of the series. The program, broadcast nationwide, is available online, and focuses on topics in psychiatry in order to educate the public, reduce stigma and offer a message of hope. Dr. Borenstein served as Editor-in-Chief of Psychiatric News, the newspaper of the American Psychiatric Association from 2012 - 2023.
Dr. Borenstein is a Fellow of the New York Academy of Medicine and serves as the Chair of the Section of Psychiatry at the Academy. He also has served as the President of the New York State Psychiatric Association. Dr. Borenstein earned his undergraduate degree at Harvard and his medical degree at New York University.
